Hemcheck Sweden AB (publ)

Hemcheck Sweden AB (publ) Share · SE0009320278 (XSTO) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Hemcheck Sweden AB (publ)
No Price
Share Float & Liquidity
Free Float 62,13 %
Shares Float 23,62 M
Shares Outstanding 38,02 M
Company Profile for Hemcheck Sweden AB (publ) Share
Hemcheck Sweden AB (publ) operates as a medical technology company in Sweden. The company develops and commercializes Helge, which detects hemolysis in blood samples at the point of care. It serves emergency departments in the European Union and the United States. The company was founded in 2010 and is based in Karlstad, Sweden.

Company Data

Name Hemcheck Sweden AB (publ)
Company Hemcheck Sweden AB (publ)
Website https://www.hemcheck.com
Primary Exchange XSTO NASDAQ STOCKHOLM AB
ISIN SE0009320278
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Joen Averstad
Country Sweden
Currency SEK
Employees 0,0 T
Address Karlstads universitet, 651 88 Karlstad
IPO Date 2017-03-15

Ticker Symbols

Name Symbol
NASDAQ STOCKHOLM AB HEMC.ST
More Shares
Investors who hold Hemcheck Sweden AB (publ) also have the following shares in their portfolio:
BCO SANTAND. 25/32 MTN
BCO SANTAND. 25/32 MTN Bond
BRIT.AMER.TOBACCO ADR/
BRIT.AMER.TOBACCO ADR/ Depository Receipt